Protease-activated receptor 1: A role in prostate cancer metastasis

Ta Chun Yuan, Ming-Fong Lin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Protease-activated receptor (PAR) 1, PAR3, and PAR4 are considered "thrombin receptors" because thrombin specifically cleaves the extracellular N-termini of the receptor to unmask a new amino acid terminus, which in turn acts as a peptide ligand by binding intramolecularly to the body of the receptor. Among those 3 family members, PAR1 is the predominant thrombin receptor. Although the thrombin-mediated regulation of clot formation has been studied extensively over the past decades, the possible role of thrombin in tumor metastasis via PAR1 has only recently received attention and is briefly discussed herein.

Original languageEnglish (US)
Pages (from-to)189-191
Number of pages3
JournalClinical Prostate Cancer
Volume3
Issue number3
DOIs
StatePublished - Dec 2004

Fingerprint

PAR-1 Receptor
Thrombin
Thrombin Receptors
Prostatic Neoplasms
Neoplasm Metastasis
Ligands
Amino Acids
Peptides
Neoplasms

Keywords

  • Angiogenesis
  • Cell adhesion
  • Cytoskeletal reorganization
  • G protein-coupled receptor
  • Mitogenesis
  • RhoA
  • Thrombin receptor activating peptide

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Protease-activated receptor 1 : A role in prostate cancer metastasis. / Yuan, Ta Chun; Lin, Ming-Fong.

In: Clinical Prostate Cancer, Vol. 3, No. 3, 12.2004, p. 189-191.

Research output: Contribution to journalArticle

@article{c4574479d27249699ce543d950fb16bd,
title = "Protease-activated receptor 1: A role in prostate cancer metastasis",
abstract = "Protease-activated receptor (PAR) 1, PAR3, and PAR4 are considered {"}thrombin receptors{"} because thrombin specifically cleaves the extracellular N-termini of the receptor to unmask a new amino acid terminus, which in turn acts as a peptide ligand by binding intramolecularly to the body of the receptor. Among those 3 family members, PAR1 is the predominant thrombin receptor. Although the thrombin-mediated regulation of clot formation has been studied extensively over the past decades, the possible role of thrombin in tumor metastasis via PAR1 has only recently received attention and is briefly discussed herein.",
keywords = "Angiogenesis, Cell adhesion, Cytoskeletal reorganization, G protein-coupled receptor, Mitogenesis, RhoA, Thrombin receptor activating peptide",
author = "Yuan, {Ta Chun} and Ming-Fong Lin",
year = "2004",
month = "12",
doi = "10.3816/CGC.2004.n.030",
language = "English (US)",
volume = "3",
pages = "189--191",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Protease-activated receptor 1

T2 - A role in prostate cancer metastasis

AU - Yuan, Ta Chun

AU - Lin, Ming-Fong

PY - 2004/12

Y1 - 2004/12

N2 - Protease-activated receptor (PAR) 1, PAR3, and PAR4 are considered "thrombin receptors" because thrombin specifically cleaves the extracellular N-termini of the receptor to unmask a new amino acid terminus, which in turn acts as a peptide ligand by binding intramolecularly to the body of the receptor. Among those 3 family members, PAR1 is the predominant thrombin receptor. Although the thrombin-mediated regulation of clot formation has been studied extensively over the past decades, the possible role of thrombin in tumor metastasis via PAR1 has only recently received attention and is briefly discussed herein.

AB - Protease-activated receptor (PAR) 1, PAR3, and PAR4 are considered "thrombin receptors" because thrombin specifically cleaves the extracellular N-termini of the receptor to unmask a new amino acid terminus, which in turn acts as a peptide ligand by binding intramolecularly to the body of the receptor. Among those 3 family members, PAR1 is the predominant thrombin receptor. Although the thrombin-mediated regulation of clot formation has been studied extensively over the past decades, the possible role of thrombin in tumor metastasis via PAR1 has only recently received attention and is briefly discussed herein.

KW - Angiogenesis

KW - Cell adhesion

KW - Cytoskeletal reorganization

KW - G protein-coupled receptor

KW - Mitogenesis

KW - RhoA

KW - Thrombin receptor activating peptide

UR - http://www.scopus.com/inward/record.url?scp=11144231266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144231266&partnerID=8YFLogxK

U2 - 10.3816/CGC.2004.n.030

DO - 10.3816/CGC.2004.n.030

M3 - Article

C2 - 15634362

AN - SCOPUS:11144231266

VL - 3

SP - 189

EP - 191

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -